People with nonalcoholic fatty liver disease cirrhosis fare worse before and after liver transplant surgery if they are not overweight than if they are, according to new research presented at the 2021 Liver Meeting. “NAFLD is one of the leading etiologies of liver disease among adults awaiting liver transplantation, and non-overweight individuals with NAFLD represent a subset of patients with a distinct risk factor profile characterized by increased visceral adipose tissue, underlying insulin resistance and genetic predisposition,” said lead study author Pedro Ochoa-Allemant, MD, a resident in the Department of Internal Medicine at Yale School of Medicine, in New Haven,…
Author: Praveen Suthrum
Background The majority of endoscopic antireflux procedures for GERD are cumbersome to use and randomised long-term data are sparse. We conducted such a trial to determine the efficacy and safety of a novel, easy to use endoscopic full-thickness fundoplication (EFTP) device in patients with GERD. Design Patients with proton pump inhibitor (PPI)-dependent GERD were randomised to either EFTP or a sham procedure in 1:1 ratio. The primary endpoint was ≥50% improvement in the health-related quality of life (GERD-HRQL) score at 3 months. Secondary end points included improvement in GERD-HRQL, reflux symptom scores, PPI usage, oesophageal acid exposure and reflux episodes and endoscopic…
WASHINGTON — Medicare payments to physicians don’t need to be increased next year, the Medicare Payment Assessment Commission (MedPAC) said Tuesday in a report to Congress. “Overall, access to clinician services for Medicare beneficiaries appears stable and comparable to that for privately insured individuals,” the commissioners said in their 604-page report, one of two reports the commission is required to send Congress each year. Although the pandemic makes it difficult to assess beneficiaries’ quality of care, “we expect volume and revenue to return to pre-pandemic levels (or higher) by 2023. Therefore, the commission does not see a reason to diverge from…
InTandem Capital Partners is launching Vivo Infusion, a new network of ambulatory infusion centers (AIC) created via the firm’s simultaneous investments in MPP Infusion Centers and ID Consultants. Why it matters: With patient demand for infusion and injection care expanding — and the supply of available therapies on this front also growing — more cost-effective, quality providers are needed, InTandem senior managing director Brad Coppens tells Axios.
Similar to radiofrequency ablation, cryoballoon ablation (CBA) is a durable approach that can eradicate Barrett’s esophagus (BE) in treatment-naive patients with dysplastic BE, according to a single-center cohort study.
Guardant Health has received three new approvals from the Japanese Ministry of Health, Labor, and Welfare (MHLW) for its Guardant360 CDx liquid biopsy test. The MHLW has cleared Guardant360 CDx for mutation profiling in patients with advanced solid tumors. In addition, it approved Guardant360 CDx as a companion diagnostic for identifying patients with microsatellite instability-high solid tumors who may benefit from pembrolizumab (Keytruda). What’s more, Guardant360 CDx has also been approved for patients with MSI-High advanced colorectal cancer who may benefit from nivolumab (Opdivo).
Approximately one-third of people between 45 and 49 years of age who undergo colonoscopies have neoplastic colorectal pathology, according to a retrospective analysis. According to the researchers, led by Parth Trivedi, MD, of the Icahn School of Medicine at Mount Sinai, New York, there has progressively been a “disturbing” rise in early-onset colorectal cancer (CRC) in the United States, which has prompted guidelines from the American Cancer Society to the U.S. Preventive Services Task Force to recommend lowering the CRC screening starting age to 45 years old for average-risk individuals. Despite these recommendations, little research to date has fully characterized…
Wearable gadget technology is gaining popularity and is used in the field of GI to diagnose, manage and possibly prevent GI disorders.
ORLANDO, Florida—For all the industry’s talk about disruptors overhauling the current healthcare ecosystem, major retail and primary care players are adamant that their success depends on playing nice with traditional care delivery organizations. Speaking at the Healthcare Information and Management Systems Society (HIMSS) Global Conference in Orlando, Florida, One Medical Chief Network Officer John Singerling said his company makes a point to “digitally and clinically” integrate with a major health system partner in each of its active markets. Doing so allows the company to expand its service offerings beyond primary care, he said, linking patients to specialists, lab services or…
Scientists at the Earlham Institute, Quadram Institute and University of East Anglia on the Norwich Research Park, have developed a new computational biology method to better understand IBD for targeted clinical treatments. By analysing specific differences in gut cell types, the study deciphers cellular crosstalk to identify how beneficial bacteria communicate with our immune system to treat IBD and reduce gut inflammation.